Epirubicin in treatment and recurrence prophylaxis of patients with superficial bladder cancer.
Burk
K
K
Farmitalia Carlo Erba GmbH/D-Freiburg.
Kurth
K H
KH
Newling
D
D
D000283:Administration, Intravesical; D002278:Carcinoma in Situ / Q000188:drug therapy / Q000601:surgery; D002291:Carcinoma, Papillary / Q000188:drug therapy / Q000601:surgery; D003131:Combined Modality Therapy; D015251:Epirubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007322:Instillation, Drug; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D011379:Prognosis; D001743:Urinary Bladder / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000601:surgery
D015251:Epirubicin